Solventum (NYSE:SOLV) today announced that it’s launched its VAC Peel and Place Dressing, with an all-in-one, extended-wear design to enhance negative pressure wound therapy.

Femasys today announced it received FDA 510(k) clearance for its FemChec contrast-generating device that checks fallopian tubal status.

DeepWell Digital Therapeutics (DTx) has won FDA 510(k) clearance of technology to be used in immersive media like video games for stress reduction and as an adjunctive treatment for high blood pressure.

Apple today unveiled new sleep and hearing health features for its Apple Watch and AirPods Pro 2, expanding its health metrics offerings.

MGI Tech Co., Ltd. (“MGI”), a company committed to building core tools and technologies that drive innovation in life science, today announced the global rights to commercialize and distribute the new sequencing products CycloneSEQ-WT02* and CycloneSEQ-WY01*

The company says the minimally invasive system is set to ‘revolutionise’ care for patients as it allows for two separate devices to communicate for the first time.

For the first time, neuroscientists have developed a way to address debilitating PMS and menstrual pain symptoms without relying on drugs, hormones, or enduring severe side effects.

Researchers at ETH Zurich have managed to make sound waves travel only in one direction. In the future, this method could also be used in technical applications with electromagnetic waves.